Study indicates lipolytic effects with nominal impact on insulin sensitivity. The peptide has gone through human trials with frequently favorable security profiles, nevertheless FDA approval for medical use continues to be absent. No. Retatrutide is offered only as a result of clinical trials and is not offered in pharmacies being an approved me